125 related articles for article (PubMed ID: 38552897)
1. The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection.
Rigo I; Young MK; Abhyankar MM; Xu F; Ramakrishnan G; Naz F; Madden GR; Petri WA
Anaerobe; 2024 Jun; 87():102842. PubMed ID: 38552897
[TBL] [Abstract][Full Text] [Related]
2. Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.
Gilbert J; Leslie J; Putler R; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
Anaerobe; 2021 Feb; 67():102299. PubMed ID: 33227427
[TBL] [Abstract][Full Text] [Related]
3. IgG antibody response to toxins A and B in patients with Clostridium difficile infection.
Wullt M; Norén T; Ljungh A; Åkerlund T
Clin Vaccine Immunol; 2012 Sep; 19(9):1552-4. PubMed ID: 22787196
[TBL] [Abstract][Full Text] [Related]
4. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
5. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
6. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
[TBL] [Abstract][Full Text] [Related]
7. Effective definition of low humoral response to Clostridioides difficile infection.
Ramos-Martínez A; Serrano-Martínez F; Pintos I; Valencia-Alijo Á; Gutiérrez-Rojas Á; Cítores MJ; Ortiz-Balbuena J; Royuela A; Martínez-Ruiz R; Sánchez-Romero I; Asensio Á; Múñez E; Plaza A
Anaerobe; 2021 Dec; 72():102475. PubMed ID: 34752901
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.
Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS
Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683
[No Abstract] [Full Text] [Related]
9. Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.
Johnston PF; Gerding DN; Knight KL
Infect Immun; 2014 Feb; 82(2):522-31. PubMed ID: 24478068
[TBL] [Abstract][Full Text] [Related]
10. Development of a new serological assay for the diagnosis of Clostridium difficile infections with prognostic value.
von Bechtolsheim F; Varga A; Szereday L; Polgar B; Balassa T; Kocsis B; Peterfi Z; Miko E
J Microbiol Methods; 2019 Dec; 167():105777. PubMed ID: 31733265
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.
Amadou Amani S; Shadid T; Ballard JD; Lang ML
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095
[TBL] [Abstract][Full Text] [Related]
12. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.
Shah HB; Smith K; Scott EJ; Larabee JL; James JA; Ballard JD; Lang ML
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663199
[TBL] [Abstract][Full Text] [Related]
13. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
14. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.
Amadou Amani S; Lang GA; Ballard JD; Lang ML
Infect Immun; 2021 Sep; 89(10):e0027421. PubMed ID: 34097471
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response as predictor of recurrence in Clostridium difficile infection.
Bauer MP; Nibbering PH; Poxton IR; Kuijper EJ; van Dissel JT
Clin Microbiol Infect; 2014 Dec; 20(12):1323-8. PubMed ID: 25041274
[TBL] [Abstract][Full Text] [Related]
16. Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.
Devera TS; Lang GA; Lanis JM; Rampuria P; Gilmore CL; James JA; Ballard JD; Lang ML
Infect Immun; 2016 Jan; 84(1):194-204. PubMed ID: 26502913
[TBL] [Abstract][Full Text] [Related]
17. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.
Romano MR; Leuzzi R; Cappelletti E; Tontini M; Nilo A; Proietti D; Berti F; Costantino P; Adamo R; Scarselli M
Toxins (Basel); 2014 Apr; 6(4):1385-96. PubMed ID: 24759173
[TBL] [Abstract][Full Text] [Related]
19. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
[TBL] [Abstract][Full Text] [Related]
20. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
